Ellen ‘t Hoen named one of the “50 Most Influential People in IP”

For Ellen ‘t Hoen’s “fierce” advocacy on access to medicine, and in particular for her efforts under the Covid-19 pandemic to ensure knowledge and intellectual property sharing relevant to treating COVID, she has been recognised by the journal Managing IP as one of 2020’s most influential people in intellectual property under the category of “notable individuals”.

Ellen has written and spoken widely on the need for any technology needed for an effective response to the global pandemic to become a global public good, and her articles and interviews have attracted much-needed attention to the World Health Organization’s COVID-19 Technology Access Pool. This mechanism is intended to ensure know-how and intellectual property that could help stop the pandemic is shared, as no one country or company could possibly meet the volume or urgency of need.

This is Ellen’s 5th recognition by Managing IP. She was also recognised as one of IP’s most influential in 2005, 2006, 2010 and 2011.

Also in the category of “notable individuals” working on Covid this year are Diane Peters, the general counsel at Creative Commons, for posting an “Open Covid Pledge” where companies could offer their IP to anyone committed to using it against the pandemic; and Christian Fracassi, who bypassed IP rights by publishing a reverse-engineered file allowing anyone with a 3D printer to make replacement valves for respiratory machines needed to treat Covid patients. For non-Covid issues, Emmanuelle Charpentier and Jennifer Doudna were recognised for their discovery of gene editing technique CRISPR-Cas9, for which they won this year’s Nobel Prize in chemistry; George Floyd, whose killing by police sparked a necessary global conversation on racism and in the IP world a series of rebranding over racially charged logos; and Stephen Thaler, who tried (and failed) to secure patent protection over technologies invented by an artificial intelligence rather than a person.

 

 

Avatar photo
+ posts

Kaitlin Mara, MSc, has been writing about international intellectual property and innovation policy for a over 15 years.

Newsletter

Never miss a post! Sign up for ML&P's newsletter.

Recent Articles

Will Europe block the Pandemic Agreement because of one word?

This commentary originally appeared in the Brussels Times, and is available here. The Pandemic Agreement negotiations began in December of 2021. Sufficiently motivated by the...

“Mutually agreed terms and conditions,” says it all.

On 4 March, Politico reported that the Polish presidency of the Council of the European Union (EU) is expressing doubt that the Pandemic Agreement...

“This week, the medicines were not there”: What is at stake in the pandemic agreement

Earlier this week I listened to a testimony from a community worker at a maternity ward where HIV-positive women gave birth. 17 babies were...

A better way to solve a crisis: A new mechanism for incentivising R&D on new antimicrobials

Antimicrobial resistance is the ‘silent’ pandemic: Globally, it costs 5 million lives a year, and is set to rise to more than 8 million...

The world needs a signal that multilateralism works: ML&P opening statement to the INB13, 17 February 2025

Thank you for the opportunity to make a brief statement. The negotiations for the Pandemic Agreement enter the final phase. We hope and wish for...

Related Articles